MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202511113510 A) filed by Eras Lucknow Medical College & Hospital; American University Of Barbados; Mr. Mohsin Ali Khan; Mr. Zaw Ali Khan; Ms. Kinza Zehra; and Ms. Sarina Zehra, Lucknow, Uttar Pradesh, on Nov. 18, 2025, for 'targeted dietary supplementation for migraine prevention and management.'
Inventor(s) include Mr. Mohsin Ali Khan; Mr. Zaw Ali Khan; Ms. Kinza Zehra; and Ms. Sarina Zehra.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a novel targeted dietary supplementation system for the prevention and management of migraine that integrates personalized nutritional protocols with neurological pathway modulation mechanisms, facilitating comprehensive migraine management through bioactive compounds, neurotransmitter balancing, and neuroinflammation reduction while maintaining optimal mitochondrial function and metabolic profile optimization for enhanced patient outcomes and quality of life improvement. The comprehensive migraine management framework employs adaptive nutritional algorithms and targeted supplementation protocols, utilizing specialized bioactive delivery systems and metabolically-optimized formulations to ensure effective neurological pathway modulation, enhanced mitochondrial support, and optimal neurotransmitter regulation while maintaining continuous therapeutic monitoring capabilities. The integrated methodology combines multi-pathway neurological intervention techniques with personalized nutrition-driven therapeutic systems, leveraging variable-dosage supplementation signals and multi-factor biomarker indicators to optimize treatment procedures and management workflows for maximum therapeutic efficacy and minimal side effects during critical migraine prevention applications. The novel responsive nutritional architecture features engineered high-bioavailability supplementation components with specialized neurological pathway targeting protocols, enabling complex multi-stage therapeutic intervention while ensuring treatment consistency and therapeutic optimization across various patient populations without compromising system safety and efficacy."
Disclaimer: Curated by HT Syndication.
